Compare Stocks → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BLUCVE:SDX Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsSDXSDX EnergyC$0.37-5.1%C$0.37C$0.33▼C$1.20C$75.75MN/A122,122 shs783,993 shsElon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%+106.44%SDXSDX Energy0.00%0.00%0.00%0.00%0.00%Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS Health0.0948 of 5 stars1.10.00.00.00.63.30.0SDXSDX EnergyN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS Health2.25Hold$14.750.07% UpsideSDXSDX EnergyN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77SDXSDX EnergyC$55.40M1.37C$0.05 per share6.73C$0.57 per share0.65Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/ASDXSDX EnergyN/AN/A370.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/ASDXSDX EnergyN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42SDXSDX Energy1.702.402.06OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%SDXSDX EnergyN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%SDXSDX EnergyN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableSDXSDX EnergyN/A204.72 millionN/ANot OptionableBLU, IGAS, SDX, and ZOL HeadlinesSourceHeadlineSDX Energy (CVE:SDX) Stock Crosses Below Fifty Day Moving Average of $0.37americanbankingnews.com - March 22 at 5:44 AMLand Drill Rigs Market Poised for Robust Growth with Revenue Surpassing $43.8 Billion by 2023uk.finance.yahoo.com - March 12 at 1:56 PMbp looking at potential new sources of gas beyond Shah Denizen.trend.az - March 1 at 7:58 AMSDx redesigns enterprise fabric across sectorsit-online.co.za - February 23 at 7:54 AMSDX Energy Share Chatlse.co.uk - February 6 at 2:17 PMCompany news: Scott Fleischer and Tom Paul promoted by Barclay Damon law firmmsn.com - January 22 at 4:01 PMOppenheimer Is the Least Interesting Character in the Moviemsn.com - January 19 at 9:39 AMWhy a near record negative NAO index will bring cold and the snowiest weather in yearstheglobeandmail.com - January 7 at 8:04 PMShah Deniz exploration well reaches planned total depth (Exclusive)en.trend.az - January 7 at 10:04 AMScientists Confirm Some People Really Can Smell When Rain Is Comingmsn.com - December 6 at 3:33 PMSDX Energy: Corporate Strategy Updatecbonds.com - November 29 at 8:53 AMSDX Energy pivoting away from Egyptian assetssharecast.com - November 27 at 5:15 PMEXECUTIVE CHANGES: Ocean Harvest catches new CFO, Titon hires new CEOlse.co.uk - November 22 at 9:57 AMbp in preparation for commencing drilling of first production well from ACE platform this month - Bakhtiyar Aslanbayli (Exclusive interview)en.trend.az - November 15 at 11:26 PMSDX Energy Shares Rise on Receipt of $1.9 Mln Prepayment for Gasmarketwatch.com - October 5 at 10:37 AMSDX Energy receives $1.9m pre-payment from Citic subsidiarysharecast.com - October 5 at 10:37 AMSDX Energy finds gas-charged sands in new wellsharecast.com - September 28 at 3:20 PMSDX Energy spuds Moroccan wellogj.com - September 5 at 4:09 PMSDX to Divest Egypt Assets, Focus on Morocco Energy Transitionrigzone.com - September 4 at 7:35 AMSDX signs heads of terms for disposal of its Egyptian assetsnaturalgasworld.com - August 31 at 3:25 AMUK Net Mortgage Approvals Fall As Interest Rates Remain Highmorningstar.com - August 30 at 5:23 PMFTSE 100 Ends Higher, Helped by Hopes of US Rate Pausemorningstar.com - August 30 at 5:23 PMADES intends to offer 30% stake on Saudi's Tadawul before 2023-endzawya.com - August 22 at 2:28 AMSmall-cap movers: WH Ireland shares fold amid brokerage bear cycleproactiveinvestors.co.uk - July 28 at 3:29 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Waysbluebird bio stock is ripe for a 400% institutional short squeezeFebruary 27, 2024 6:45 AMView bluebird bio stock is ripe for a 400% institutional short squeezebluebird bio Stock Signals Potential to be a Multi-bagger February 29, 2024 9:55 AMView bluebird bio Stock Signals Potential to be a Multi-bagger bluebird bio: How to play LEAPS options for growth and income February 27, 2024 8:00 AMView bluebird bio: How to play LEAPS options for growth and income Beam Therapeutics Bolts Higher on Gene Therapy Licensing PaymentsMarch 6, 2024 6:19 AMView Beam Therapeutics Bolts Higher on Gene Therapy Licensing PaymentsAll Headlines Company DescriptionsBELLUS HealthNASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.SDX EnergyCVE:SDXSDX Energy Inc. engages in the exploration, development, and production of oil and gas primarily in the Arab Republic of Egypt and the Kingdom of Morocco. The company holds a 50% working interest in producing assets in the North West Gemsa and Meseda located onshore in the Eastern Desert, adjacent to the Gulf of Suez; 75% working interest in the Sebou concession situated in the Gharb Basin; and 12.75% working interest in development assets in the South Ramadan concession. It also holds a 55% working interest in exploration asset in the South Disouq concession; and 75% working interest in the Lalla Mimouna and the Gharb Centre concessions. The company is headquartered in London, the United Kingdom. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.